Loading clinical trials...
Loading clinical trials...
An Observational Study of Mother-Infant Outcomes Following Antenatal Exposure to Direct-Acting Antivirals: the Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Conditions
Interventions
Direct Acting Antivirals
Locations
1
United States
The Taskforce for Global Health
Atlanta, Georgia, United States
Start Date
February 11, 2022
Primary Completion Date
June 30, 2026
Completion Date
December 30, 2026
Last Updated
December 18, 2024
NCT06953479
NCT04162938
NCT03135886
NCT05968573
NCT01644903
NCT05042544
Lead Sponsor
The Task Force for Global Health
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions